| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.75B | 22.63B | 21.97B | 18.37B | 13.67B | 12.03B |
| Gross Profit | 14.39B | 13.88B | 12.84B | 11.90B | 12.11B | 12.06B |
| EBITDA | 4.34B | 4.29B | 4.00B | 3.20B | 4.48B | 4.73B |
| Net Income | 3.06B | 2.94B | 2.69B | 1.94B | 2.77B | 2.69B |
Balance Sheet | ||||||
| Total Assets | 392.17B | 366.05B | 353.24B | 297.26B | 301.45B | 314.62B |
| Cash, Cash Equivalents and Short-Term Investments | 6.52B | 146.02B | 134.55B | 136.24B | 146.20B | 183.45B |
| Total Debt | 30.18B | 29.80B | 36.79B | 24.37B | 18.27B | 15.18B |
| Total Liabilities | 364.42B | 338.21B | 327.91B | 273.46B | 276.26B | 287.26B |
| Stockholders Equity | 27.74B | 27.84B | 25.33B | 23.80B | 25.19B | 27.36B |
Cash Flow | ||||||
| Free Cash Flow | -11.85B | 4.29B | -14.14B | -126.00M | 11.22B | -7.52B |
| Operating Cash Flow | -11.22B | 5.35B | -13.21B | 690.00M | 11.95B | -6.71B |
| Investing Cash Flow | -2.80B | -13.05B | -39.48B | 12.74B | 6.82B | -2.17B |
| Financing Cash Flow | 27.02B | 8.99B | 51.79B | -13.35B | -18.43B | 9.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $42.30B | 11.53 | 11.09% | 2.43% | 1.43% | 10.86% | |
75 Outperform | $43.06B | 11.33 | 61.59% | 1.26% | 6.45% | 36.14% | |
74 Outperform | $92.23B | 12.56 | 13.48% | 1.71% | 1.89% | 31.72% | |
73 Outperform | $30.83B | 12.32 | 14.45% | 2.21% | -5.75% | -10.69% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | $18.08B | 26.29 | 14.18% | 2.30% | -9.67% | -21.10% |